CompletedNot applicableNCT02655887
BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease
Studying May-Thurner syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- C. R. Bard
- Principal Investigator
- Michael Dake, MD, M.DLead Principal Investigator
- Intervention
- VENOVO™ Venous Stent(device)
- Enrollment
- 170 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2016 – 2020
Study locations (21)
- Vascular Breakthroughs, LLC, Darien, Connecticut, United States
- Yale University, New Haven, Connecticut, United States
- Midwest Cardiovascular Research Foundation, Davenport, Iowa, United States
- Metro Health Hospital, Wyoming, Michigan, United States
- Cox Medical Centers, Springfield, Missouri, United States
- Mount Sinai Medical Center, New York, New York, United States
- North Carolina Heart and Vascular, Raleigh, North Carolina, United States
- Cardiothoracic and Vascular Surgeons, Austin, Texas, United States
- Centra Health, Inc., dba Stroobants Cardiovascular Center, Lynchburg, Virginia, United States
- Sentara Medical Group, Virginia Beach, Virginia, United States
- Lake Washington Vascular, PLLC, Bellevue, Washington, United States
- CAMC Health Education and Research Institute, Charleston, West Virginia, United States
- Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
- JMLS Medical Services PTY LTDT/A PERTH INST. of VASCULAR RESEARCH, Perth, Western Australia, Australia
- Uniklinik RWTH, Aachen, Germany
- +6 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02655887 on ClinicalTrials.govOther trials for May-Thurner syndrome
Additional recruiting or active studies for the same condition.